Search Market Research Report
Biotechnology Instruments Market Size, Share Global Analysis Report, , 2021 – 2026
Biotechnology Instruments Market Product (Lab Automation Instruments, Life Science Consumables, IVD Instruments, and Medical Lasers), and End-User (Government & Academic Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026
Industry Insights
According to the report published by Facts and Factors, global demand for the biotechnology instruments market was estimated at approximately USD 41,006.2 Million in 2020 and is expected to generate revenue of around USD 80,051.1 Million by the end of 2026, growing at a CAGR of around 12.66% between 2021 and 2026.
Market Overview
Biomedical Instrumentation or Bioinstrumentation refers to the application of biomedical engineering that is focusing on the devices and mechanics, which are used in measuring, evaluating, and treating biological systems.
Industry Growth Factor
The global market of biotechnology instruments is expected to grow at a significant growth rate during the forecast period. The high adoption of point-of-care diagnostic devices is a key growth factor that is driving the growth of the global biotechnology instruments market. Moreover, the huge increase in demand for biotechnology products for the production of personalized medicine is likely to propel the global market of biotechnology instruments in the upcoming years.
Furthermore, the continuous developments in research and development have improved the capabilities of point-of-care (POC) testing systems. The novel equipment presents an extensive menu of tests that is able used in numerous hospital settings. The novel POC devices let real-time transmission of test results to the electronic medical record of patients to get an effortless review from physicians. The systems are designed in a method, where they can effortlessly meet the terms with changes in laboratory regulations.
Moreover, the increasing occurrence of chronic disorders such as diabetes, cancer, and heart diseases, cardiovascular disorders, as well as infectious diseases like COVID-19, and others, is also anticipated to boost the global biotechnology instruments market escalation. Besides, the immense increase in the use of 2D and 3D cell cultures in the area of discovery and manufacture of novel drug compounds is propelling the expansion of the global biotechnology instruments market. The growing research activities surrounding gene expression, mainly since the initiation of the Human Genome Project, have further advanced the global demand for microarrays for studying the genotype or gene clusters expression, boosting the global market of biotechnology instruments.
Segmentation Analysis
The global biotechnology instruments market has been segmented into product and end-user. On the basis of product, the global biotechnology instruments market has been classified into lab automation instruments, life science consumables, IVD instruments, and medical lasers. In terms of the end-user industry, the global biotechnology instruments market has been bifurcated into government & academic institutes, pharmaceutical & biotechnology companies, hospitals & healthcare facilities, and others.
Report Scope
Report Attribute |
Details |
Market Size in 2020 |
USD 41,006.2 Million |
Projected Market Size in 2026 |
USD 80,051.1 Million |
CAGR Growth Rate |
12.66% CAGR |
Base Year |
2020 |
Forecast Years |
2021-2026 |
Key Market Players |
Agilent Technologies, Becton Dickinson, and Company, Abbott, Alcon Inc., AngioDynamics, Bio-Rad Laboratories, BioMerieux SA, BioTek Instruments Inc., Cynosure LLC, Candela Medical, Endress+Hauser (Analytik Jena GmbH), Danaher Corporation, IIlumina Inc., F. Hoffmann-La Roche Ltd., IRIDEX, Merck KGaA, Lumenis, Perkin Elmer Inc., Novanta Inc., Siemens Healthineers, QIAGEN, Waters Corporation, Tecan Group AG, Zimmer MedizinSysteme GmbH, and Thermo Fisher Scientific Inc., and among others. |
Key Segment |
By Product, By End-User, and By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Analysis
The global biotechnology instruments market has been classified into North America, Latin America, Asia-Pacific, Europe, the Middle East, and Africa. In terms of revenue, North America is accounted for the largest market share in the global biotechnology instruments market. The high growth in this regional market can be attributed to the growing demand, the preference for manual automation in the pharmaceuticals, biotechnology, and associated industries in the region, the affordability of biotechnology instruments, and the rising demand for highly developed instruments to ease and speed up the procedure. Also, the accessibility of government funding for research and development activities is likely to drive market development.
The region of Asia-Pacific is anticipated to become the fastest-growing market during the forecast period. This is due to the increase in investments in the biotechnology area and the fast-developing economy.
Competitive Players
The major market players covered in the global biotechnology instruments market include:
- Agilent Technologies
- Becton Dickinsonand Company
- Abbott
- Alcon Inc.
- AngioDyanamics
- Bio-Rad Laboratories
- BioMerieux SA
- BioTek Instruments Inc.
- Cynosure LLC
- Candela Medical
- Endress+Hauser (Analytik Jena GmbH)
- Danaher Corporation
- IIlumina Inc.
- F. Hoffmann-La Roche Ltd.
- IRIDEX
- Merck KGaA
- Lumenis
- Perkin Elmer Inc.
- Novanta Inc.
- Siemens Healthineers
- QIAGEN
- Waters Corporation
- Tecan Group AG
- Zimmer MedizinSysteme GmbH
- Thermo Fisher Scientific Inc.
Product Segment Analysis
- Lab Automation Instruments
- Life Science Consumables
- IVD Instruments
- Medical Lasers
End-User Segment Analysis
- Government & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Healthcare Facilities
- Others
Regional Segment Analysis
- North America
- U.S.
- Canada
- Europe
- U.K.
- France
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- The Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East Africa
Table of Content
Industry Major Market Players
- Agilent Technologies
- Becton Dickinsonand Company
- Abbott
- Alcon Inc.
- AngioDyanamics
- Bio-Rad Laboratories
- BioMerieux SA
- BioTek Instruments Inc.
- Cynosure LLC
- Candela Medical
- Endress+Hauser (Analytik Jena GmbH)
- Danaher Corporation
- IIlumina Inc.
- F. Hoffmann-La Roche Ltd.
- IRIDEX
- Merck KGaA
- Lumenis
- Perkin Elmer Inc.
- Novanta Inc.
- Siemens Healthineers
- QIAGEN
- Waters Corporation
- Tecan Group AG
- Zimmer MedizinSysteme GmbH
- Thermo Fisher Scientific Inc.
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors